tofacitinib,adalimumab
pfizer,abbvie
['tofa']
baker et al. optum database study. tofa assoc reduced incident ra-ild. ahr 0.33 (vs ada) #acr22 abstr#2251 #acrbest 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC